Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ZI-MA4-1a |
| Trade Name | |
| Synonyms | ZI-MA41a|ZI MA4-1a|ZIMA4-1a |
| Drug Descriptions |
ZI-MA4-1a comprises allogeneic NK cells expressing an engineered TCR targeting an HLA-A*02:01-restricted MAGEA4 peptide and expressing a CD3 complex with a CD8 co-receptor, which potentially induces cytokine production and inhibits tumor growth (PMID: 41480010). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ZI-MA4-1a | ZI-MA4-1a | 0 | 1 |